ストックスクリーナーアプリを入手
1.23
1.65%
0.02
前日終値:
$1.21
開ける：
$1.23
24時間の取引高:
1.65M
Relative Volume:
0.70
時価総額：
$85.59M
収益：
$151.64M
当期純損益:
$-37.23M
株価収益率:
-2.2511
EPS:
-0.5464
ネットキャッシュフロー:
$-13.58M
1週間 パフォーマンス:
-6.11%
1か月 パフォーマンス:
+4.24%
6か月 パフォーマンス:
-13.07%
1年 パフォーマンス:
-63.61%
1日の値動き範囲:
$1.20
$1.2981
1週間の範囲:
$1.19
$1.3888
52週間の値動き範囲:
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
Compare STIM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.23 | 85.59M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-10-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 開始されました | BTIG Research | Buy |
| 2018-07-24 | 開始されました | Canaccord Genuity | Buy |
すべてを表示
Neuronetics Inc (STIM) 最新ニュース
Neuronetics Inc (STIM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Neuronetics Inc (STIM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Neuronetics Inc (STIM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Neuronetics Inc (STIM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Neuronetics Inc (STIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Neuronetics Inc (STIM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Neuronetics Inc (STIM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Neuronetics (NASDAQ: STIM) director reallocates 42,500 shares to Madryn funds - Stock Titan
Madryn funds (NASDAQ: STIM) reallocate 72,500 Neuronetics RSU shares - Stock Titan
Neuronetics Inc (STIM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Neuronetics Names Sales Chief, Grants Equity Incentive - MyChesCo
STIM (NASDAQ) affiliate files to sell 42,164 vested shares via Fidelity - Stock Titan
STIM Technical Analysis | Trend, Signals & Chart Patterns | NEURONETICS INC (NASDAQ:STIM) - ChartMill
Neuronetics names Robert Greene as senior VP, sales - Medical Buyer
Neuronetics largest shareholder pushes for strategic review - Investing.com
Neuronetics Appoints Robert Greene as Senior Vice President Sales - The Globe and Mail
New Neuronetics sales chief gets 200,000-share stock grant - Stock Titan
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026 - The Manila Times
New TMS data on teen and adult depression at CTMSS 2026 - Stock Titan
Neuronetics Stock Drops As Traders Watch New TMS Research Effort - Bez Kabli
Neuronetics, Inc. (STIM) Submits Form 8-K Reporting Shareholder Vote Results – Key Filing Details and Company Information - Minichart
What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM) - Kavout
Neuronetics (STIM) director Megan Rosengarten granted 30,000 RSUs, now holds 170,890 shares - Stock Titan
Director at Neuronetics (STIM) receives 30,000-share RSU grant - Stock Titan
Neuronetics (STIM) director awarded 30,000 RSUs vesting by 2027 - Stock Titan
Neuronetics (STIM) director Sheryl Conley awarded 30,000 RSUs in stock grant - Stock Titan
Neuronetics (STIM) director granted 36,250 RSUs, holdings rise to 625,017 shares - Stock Titan
Neuronetics (STIM) director Avinash Amin receives 30,000 RSU equity award - Stock Titan
Neuronetics (STIM) shareholders back directors, auditor and 2026 equity plan - Stock Titan
Neuronetics Inc stock (US63009R1005): Nasdaq shares steady as investors look beyond Q1 update - AD HOC NEWS
Neuronetics Inc stock (US63009R1005): shares little changed as investors weigh Q1 2026 update - AD HOC NEWS
Neuronetics (STIM) Holds at $1.22 as Stock Consolidates Near Key SupportActive ETF Flow - thelegaladvocate.com
PRISM MarketView Spotlights Seven Public Companies Advancing Mental Health Innovation During National Mental Health Awareness Month - StreetInsider
Large Neuronetics (STIM) holder discloses 15.17% stake and sole control - Stock Titan
STIMNeuronetics Inc Stock Price and Quote - Finviz
Neuronetics (STIM) Q1 2026 Earnings Transcript - AOL.com
Neuronetics, Inc. Signs $26,000/Month Consulting Agreement with Francis X. Brown III – 8-K Filing Details and Agreement Terms – Minichart - Minichart
Neuronetics Analyst Ratings and Price Targets | NASDAQ:STIM - Benzinga
Neuronetics Inc (STIM) Stock Price, Quote, News & History - Benzinga
Neuronetics updates consulting agreement for interim financial officer By Investing.com - Investing.com South Africa
Neuronetics updates consulting agreement for interim financial officer - Investing.com
Neuronetics (NASDAQ: STIM) sets new monthly pay for interim finance chief - Stock Titan
Neuronetics, Inc. Appoints Francis X. Brown III as Accounting Officer, Effective as of May 5, 2026 - marketscreener.com
Neuronetics (STIM) ex-CFO corrects insider sale to 8,569 tax-withheld shares - Stock Titan
STIM PE Ratio & Valuation, Is STIM Overvalued - Intellectia AI
STIM SEC FilingsNeuronetics 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Buying: Jorey Chernett Acquires 100,000 Shares of Neuron - GuruFocus
Neuronetics 10% owner Chernett buys $117,000 in common stock By Investing.com - Investing.com South Africa
Neuronetics 10% owner Chernett buys $117,000 in common stock - Investing.com UK
Neuronetics (NASDAQ: STIM) large holder buys 100,000 shares - Stock Titan
Neuronetics(STIM) Stock Options Chain | Quotes & News - Moomoo
Neuronetics Inc (STIM) 財務データ
収益
当期純利益
現金流量
EPS
Neuronetics Inc (STIM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Chernett Jorey | 10% Owner |
May 19 '26 |
Buy |
1.17 |
100,000 |
117,000 |
10,553,988 |
| Chernett Jorey | 10% Owner |
May 12 '26 |
Buy |
1.34 |
475,000 |
636,500 |
10,453,988 |
| Chernett Jorey | 10% Owner |
Apr 20 '26 |
Buy |
1.58 |
100,000 |
158,000 |
9,878,988 |
| Chernett Jorey | 10% Owner |
Apr 21 '26 |
Buy |
1.51 |
100,000 |
151,000 |
9,978,988 |
| Chernett Jorey | 10% Owner |
Mar 30 '26 |
Buy |
1.25 |
385,442 |
481,802 |
9,778,988 |
| Chernett Jorey | 10% Owner |
Mar 27 '26 |
Buy |
1.35 |
500,000 |
675,000 |
9,393,276 |
| Chernett Jorey | 10% Owner |
Mar 25 '26 |
Buy |
1.40 |
125,000 |
175,000 |
8,868,276 |
| Chernett Jorey | 10% Owner |
Mar 26 '26 |
Buy |
1.44 |
25,000 |
36,000 |
8,893,276 |
| Pfanstiel Steven | EVP, CFO and Treasurer |
Mar 19 '26 |
Sale |
1.34 |
16,431 |
22,018 |
828,781 |
| Sullivan Keith J | Former Officer & Director |
Mar 19 '26 |
Sale |
1.34 |
46,289 |
62,027 |
1,590,924 |
0.93%
大文字化:
|
ボリューム (24 時間):